These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 15329307

  • 1. Meta-analysis of the P300 and P50 waveforms in schizophrenia.
    Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S.
    Schizophr Res; 2004 Oct 01; 70(2-3):315-29. PubMed ID: 15329307
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. P300 waveform and dopamine transporter availability: a controlled EEG and SPECT study in medication-naive patients with schizophrenia and a meta-analysis.
    Chen KC, Lee IH, Yang YK, Landau S, Chang WH, Chen PS, Lu RB, David AS, Bramon E.
    Psychol Med; 2014 Jul 01; 44(10):2151-62. PubMed ID: 24238542
    [Abstract] [Full Text] [Related]

  • 4. P300 aberration in first-episode schizophrenia patients: a meta-analysis.
    Qiu YQ, Tang YX, Chan RC, Sun XY, He J.
    PLoS One; 2014 Jul 01; 9(6):e97794. PubMed ID: 24933577
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic specificity of neurophysiological endophenotypes in schizophrenia and bipolar disorder.
    Johannesen JK, O'Donnell BF, Shekhar A, McGrew JH, Hetrick WP.
    Schizophr Bull; 2013 Nov 01; 39(6):1219-29. PubMed ID: 22927673
    [Abstract] [Full Text] [Related]

  • 6. State and trait markers of emotionally charged visual event-related potentials (P300) in drug-naïve schizophrenia.
    Mori K, Morita K, Shoji Y, Matsuoka T, Fujiki R, Uchimura N.
    Psychiatry Clin Neurosci; 2012 Jun 01; 66(4):261-9. PubMed ID: 22624730
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of studies in China about changes in P300 latency and amplitude that occur in patients with schizophrenia during treatment with antipsychotic medication.
    Su L, Cai Y, Shi S, Wang L.
    Shanghai Arch Psychiatry; 2012 Aug 01; 24(4):200-7. PubMed ID: 25324627
    [Abstract] [Full Text] [Related]

  • 8. Effects of olanzapine on auditory P300 in schizophrenia.
    Gonul AS, Suer C, Coburn K, Ozesmi C, Oguz A, Yilmaz A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb 01; 27(1):173-7. PubMed ID: 12551741
    [Abstract] [Full Text] [Related]

  • 9. Meta-analysis of P300 and schizophrenia: patients, paradigms, and practical implications.
    Jeon YW, Polich J.
    Psychophysiology; 2003 Sep 01; 40(5):684-701. PubMed ID: 14696723
    [Abstract] [Full Text] [Related]

  • 10. P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication.
    Coburn KL, Shillcutt SD, Tucker KA, Estes KM, Brin FB, Merai P, Moore NC.
    Biol Psychiatry; 1998 Sep 15; 44(6):466-74. PubMed ID: 9777178
    [Abstract] [Full Text] [Related]

  • 11. [Evoked potentials N200/P300 disorders and clinical phenotype in Cuban families with paranoid schizophrenia: a family-based association study].
    Guerra López S, Martín Reyes M, Pedroso Rodríguez Mde L, Reyes Berazain A, Mendoza Quiñones R, Bravo Collazo TM, Días de Villarvilla T, Machado Cano MJ, Bobés León MA.
    Medwave; 2015 Apr 01; 15(3):e6112. PubMed ID: 25919584
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Event-related potentials and genetic risk for schizophrenia.
    Winterer G, Egan MF, Rädler T, Coppola R, Weinberger DR.
    Biol Psychiatry; 2001 Sep 15; 50(6):407-17. PubMed ID: 11566157
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].
    Asato N, Hirayasu Y, Hiramatsu K, Ohta H.
    Seishin Shinkeigaku Zasshi; 1999 Sep 15; 101(3):254-76. PubMed ID: 10375977
    [Abstract] [Full Text] [Related]

  • 19. What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?
    Korostenskaja M, Kähkönen S.
    Curr Pharm Des; 2009 Sep 15; 15(22):2573-93. PubMed ID: 19689329
    [Abstract] [Full Text] [Related]

  • 20. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
    Papageorgiou C, Oulis P, Vasios C, Kontopantelis E, Uzunoglu N, Rabavilas A, Christodoulou GN.
    Eur Neuropsychopharmacol; 2004 May 15; 14(3):227-36. PubMed ID: 15056482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.